Obstetrical disseminated intravascular coagulation (DIC) is usually a very
acute, serious complication of pregnancy. The DIC diagnostic criteria in ob
stetrics (the obstetrical DIC score) help with making a prompt diagnosis an
d starting treatment early. These DIC diagnostic criteria, in which higher
scores are given for clinical parameters than for laboratory parameters, ha
ve three components: (1) the underlying disease, (2) clinical symptoms, and
(3) laboratory findings. It is justified that it is appropriate to initiat
e therapy for DIC when the obstetrical DIC score reaches 8 points or more b
efore obtaining the results of coagulation tests. Management: (1) Control o
f the underlying disease: because prolongation of exposure to the triggerin
g factors worsens DIG, it is important to eliminate the etiologic factors a
s rapidly as possible. Elimination of the cause of DIC can be easily perfor
med in obstetrics, for example, by cesarean section. (2) Antithrombin (AT)
therapy: AT monotherapy (1500 to 3000 units/day, 2 days) is preferably empl
oyed instead of heparin monotherapy or heparin-AT therapy because of the he
morrhagic side effects of heparin. (3) Synthetic serine protease inhibitors
: continuous infusion of gabexate mesilate (FOY (R)) or nafamostat mesilate
(FUT (R)) is effective for DIG. Controlled multicenter trials showed a sig
nificant improvement not only in clinical response but also in platelet cou
nts and prothrombin time (PT) in the AT group compared with the FOY group.
(4) Activated protein C (APC) can inhibit thrombin generation and accelerat
e fibrinolytic activity. APC (5000 to 10,000 units) is administered for 2 d
ays in patients with pla cental abruption complicated by DIG. APC is a very
safe, effective, and useful agent for the treatment of DIC.